Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Gynecol Oncol. 2019 May 18;154(1):144–149. doi: 10.1016/j.ygyno.2019.05.004

Figure 1.

Figure 1.

Patients selected for inclusion

Of 3649 patients with EOC seen between 1/1/08 and 7/31/18, 91 (2.5%) were diagnosed with BM. Of these, 63 had germline testing performed. When grouped by 5-year increments, 30 of 52 (57%) patients diagnosed 1/1/2008–12/31/2012 and 33 of 39 (85%) patients diagnosed 1/1/13–7/31/18 underwent genetic testing. 21 patients had a BRCA mutation: 15, BRCA1; 6, BRCA2. 42 patients were germline BRCA mutation negative.